Sun Pharma Advanced Research Company (348.1)
Investors with a short-term perspective can consider selling the stock of Sun Pharma Advanced Research Company at current levels. Following a sharp rally between late January and early Mar...07-09-2015
07-09-2015
Sun Pharmaceutical Industries Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Sun Pharmaceutical Industries Ltd with respect to news article appearing in Mint on August 31, 2015 titled "Sun, Wockhardt recall drugs from US"Sun Pharmaceutical Industries Ltd replied stating "We hereby confirm that it is the voluntary recall initiated by our Company for certain stated medicines,.We further state that it has no/would have no material impact on Company's performance, operations or revenues."01-09-2015
Sun Pharma Rises 2% on Acquiring Opiates Business in Australia
Sun Pharma in an announcement said that it acquired GSK's two opiates manufacturing facilities in Port Fairy and Latrobe in Australia.01-09-2015
Sun Pharma announces successful completion of Opiates business acquisition in Australia
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated September 01, 2015, titled "Sun Pharma announces successful completion of Opiates business acquisition in Australia".01-09-2015
Clarification sought from Sun Pharmaceutical Industries Ltd
The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd with respect to news article appearing in Mint on August 31, 2015 titled "Sun, Wockhardt recall drugs from US." The reply is awaited.31-08-2015
US law suit may drag Sun Pharma
Shares of Sun Pharma may come under pressure, on a class action suit being filed in the US against it. Some former employees have filed a case against its US arm following shutting down of...29-08-2015
Clarifies on News Item
With reference to the news appeared in CNBC TV18 & Money control on August 28, 2015 captioned "A class action suit filed against a Sun Pharma subsidiary arm Caraco Pharmaceutical Laboratories in US by workers.", Sun Pharmaceutical Industries Ltd has Clarified to BSE as under :"We confirm that this is regarding a decision from the 6th US Circuit Court of Appeals in a class action lawsuit by some former employees of our US subsidiary Company...28-08-2015
Clarification sought from Sun Pharmaceutical Industries Ltd
The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd with reference to the news appeared in CNBC TV18 & Money control on August 28, 2015 captioned "A class action suit filed against a Sun Pharma subsidiary arm Caraco Pharmaceutical Laboratories in US by workers." "Sun Pharma faces class action suit in US over 2009 plant closures." The reply is awaited.28-08-2015
Sun Pharma secures nod for Ximino capsules
Company expects the extended-release capsules used for treating acne vulgaris will be available for patients during the fourth quarter of 201520-08-2015
Sun Pharma announces US FDA approval for XiminoTM
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated August 19, 2015 titled "Sun Pharma announces US FDA approval for XiminoTM".19-08-2015